Andy Jatis, PharmD, BCPS, BCCCP

Cards/CTICU @NorthwesternMed ~ PGY2 CC & PGY1 @MayoPharmRes ~ @UIPharmacy 2021💊 ~ Interests: MCS, anticoagulation, shock

[Andy Jatis, PharmD, BCPS, BCCCP @jatis_rx]

Propofol, a sedative hypnotic, is commonly used for RSI and procedural/ICU sedation but user beware.
Propofol Infusion Syndrome (PRIS) although rare is a devastating side effect with up to 70% mortality. But how exactly does Propofol cause PRIS ⁉️ Follow the 🧵to learn more!

[Andy Jatis, PharmD, BCPS, BCCCP @jatis_rx]

Fortunate to have some amazing research mentors during residency! Excited to see this project from PGY1 get to the finish line.

[VascularMedicine @VMJ_SVM]

Online First! What is the incidence of clinically relevant bleeding in patients with low body weight, receiving prophylactic subcutaneous heparin? @jatis_rx @nei_scott and colleagues explore further in this informative study.

https://t.co/qgirQf8WeH

[Andrea Nei @Dre_pharmd]

Happy last day of residency to @NikithaYagnala and @jatis_rx! So proud of the incredible critical care pharmacists and people you are. @PennMedicine and @NorthwesternMed are so lucky to have you join their team, we will miss you so much! @MayoPharmRes #pharmicu

[ACCPpostgrads @ACCPpostgrads]

Dr. Nick Peters from the @PharmacyToDose critical care podcast provides insight on increasing your podcasting presence. Listen now: https://t.co/qDPtXfaPP2 @jatis_rx

[ACCPpostgrads @ACCPpostgrads]

Guess what just released? Two new ACCPPostgrads podcast episodes featuring Drs. Henry Okoroike and Mia Lussier! If you're interested in hearing their experience transitioning to new practitioner roles, listen in: https://t.co/u5SwoGnhQy
@henryco32 @MiaLussier

[Ashley & Brooke Barlow PharmD @theABofPharmaC]

Next 🆙 Dr. Andy Jatis @jatis_rx discusses the ENCHATED2/MT Trial on intensive BP control after endovascular thrombectomy for acute ischemic stroke 🧠 🩺

#NCSPharmJC @neurocritical #PharmICU #NeuroTwitter

[Andy Jatis, PharmD, BCPS, BCCCP @jatis_rx]

In the ECHANTED2/MT trial patients assigned to this intensive SBP goal had worse neurologic or functional outcomes at day 7 and day 90 compared to a non-intensive SBP goal of 140-180 mmHg #NCSPharmJC (2/2)

[Andy Jatis, PharmD, BCPS, BCCCP @jatis_rx]

For a patient with acute ischemic stroke and large vessel occlusion receiving mechanical thrombectomy, what SBP goal do you target after successful endovascular reperfusion if the patient remains hypertensive?
@neurocritical #NCSPharmJC

[Andy Jatis, PharmD, BCPS, BCCCP @jatis_rx]

Clinical pearl 💊In patients with acute ischemic stroke and large vessel occlusion who remain hypertensive after successful endovascular reperfusion with thrombectomy, it is harmful to target a SBP < 120 mmHg (1/)

[Mayo Clinic Pharmacy Residency Programs @MayoPharmRes]

In today's Pharmacy Grand Rounds, @MayoClinicPharmRes @NikithaYagnala and @jatis_rx debate the role of terlipressin in hepatorenal syndrome. #TwitteRx @MayoClinicCCM @MayoClinicGIHep @accpcritprn @SCCM

Subscribe to our PGR Podcast at https://t.co/MEkVN2E3xi

[ACCPpostgrads @ACCPpostgrads]

Want to get started in peer review? Get an inside look at the peer review process, including advice on how to get started from Dr. Erika Ernst, @UIPharmacy Associate Professor and JACCP Associate Editor. @JACCPJournal @ErnstErika @jatis_rx https://t.co/IrackMIzaU

[Andrea Nei @Dre_pharmd]

Some great company at the CPP reception last night. ☺️ @SCCM_CPP @MayoPharmRes

[Mayo Clinic Pharmacy Residency Programs @MayoPharmRes]

Mayo Clinic & Mayo Clinic Health System sites are hosting a virtual information session on 11/08 from 5-6 PM central! PGY1 and PGY1 community programs from Rochester (MN), Austin (MN), Mankato (MN), Eau Claire (WI), and La Crosse (WI) will be present. Register now!

[Andy Jatis, PharmD, BCPS, BCCCP @jatis_rx]

Vasopressin is released by the posterior pituitary when IV volume is ⬇️
V1 agonism 🟰 smooth muscle vasocontraction
V2 agonism in renal collecting duct 🟰 increase water retention
Given endogenous depletion of vaso in septic shock, start it early w/ NE for multimodal support

[Andy Jatis, PharmD, BCPS, BCCCP @jatis_rx]

Crit Care Lit Review 📒 Vasopressin 💉

VASST: Adding vaso ⬇️catecholamine dose and may reduce mortality for those with lower NE dose (<15 mcg/min) in septic shock
VANISH: Adding vaso early to NE may ⬇️ need for RRT
VANCS: Vaso ⬇️acute renal failure in vasoplegic shock #PharmICU

[Andy Jatis, PharmD, BCPS, BCCCP @jatis_rx]

@zacroBID @accpcritprn @SCCM_CPP @NikithaYagnala @hannahbrokmeier @Dre_pharmd @nei_scott @pwierusz @EDWieru @KyleHessPharmD @theABofPharmaC @AJWPharm The study title is a bit misleading as the NE+DOB arm only received dobutamine if CI was <= 2.5 after fluid (Figure 1 in study). Aligning with the SSC 2021 Guidelines, NE+DOB should be reserved when concern for mix shock or can switch to EPI monotherapy.

[Andy Jatis, PharmD, BCPS, BCCCP @jatis_rx]

First stop on the PGY2 Critical Care Literature Review 🚂

Vasopressors with comparison of NE+Dobutamine vs EPI in septic shock🦠💉

🔑EPI causes type-B lactic acidosis due to its beta stimulation =⏫pyruvate dehydrogenase = ⏫ glucose and lactate independent of tissue dysoxia

[Andrea Nei @Dre_pharmd]

Tuning in to her first Mayo Clinic Pharmacy Grand Rounds. @jatis_rx PGY2 critical care resident @MayoPharmRes presenting on fluid stewardship in the ICU

[Andy Jatis, PharmD, BCPS, BCCCP @jatis_rx]

@DanielOwuraku Hey Danny! Great question, for now the competition is just open to post-graduate trainees including residents and post-doctoral fellows. Students unfortunately are not eligible this year.

[Andy Jatis, PharmD, BCPS, BCCCP @jatis_rx]

Calling all Pharmacy Residents + Fellows 📣If you are looking for a fun way to challenge your ability to interpret and visually display primary literature📚try out ACCP’s 1st ever Visual Abstract Challenge! Not sure how to get started on a visual abstract? Check out this article

[ACCPpostgrads @ACCPpostgrads]

ACCP is pleased to announce a new competition: the ACCP Visual Abstract Challenge! Open to current residents and fellows, prizes will be awarded to the top 5 participants. Read more about the competition in this month's Experts in Training: https://t.co/jyUX9FALZJ